About Apintus Labs
Apintus Labs is a company based in Thane (India). It operates as a B2B. The company has 7 employees. Apintus Labs operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Thane, India
- Employees 7
- SectorsHealthcare
- Website apintuslabs.com
- Social X Facebook
- Legal Name Apintus Labs Private Limited
- Date of Incorporation 26 May, 2015
- Jurisdiction Thane, Maharashtra, India
- Net Loss-₹59,025
FY 2023 · 0% margin
- EBITDA-₹44,025
FY 2023 · 0% margin
- Employee Count7
Associated legal entities of Apintus Labs
Apintus Labs operates through Apintus Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Apintus Labs Private Limited CIN U24100MH2015PTC264861 | Active | 26 May 2015 | Thane, Maharashtra | – | 7 | 3 | View details |
Board of directors of Apintus Labs Private Limited (Apintus Labs)
Apintus Labs Private Limited is the primary company behind Apintus Labs. The board of Apintus Labs Private Limited currently have 3 directors; the longest-serving is Shailaja Bommanpad Manohar, appointed in 2015.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shailaja Bommanpad Manohar DIN 06699773 | Director | 26 May 2015 | 11 yrs 4 mo | Apintus Labs Private Limited |
| Satish Ramshankar Varma DIN 02991631 | Director | 26 May 2015 | 11 yrs 4 mo | Apintus Labs Private Limited |
| Manohar Vishwanatham Bommanpad DIN 00698276 | Director | 09 May 2016 | 10 yrs 5 mo | Apintus Labs Private Limited |
Financials of Apintus Labs
Figures of Apintus Labs Private Limited, the primary company behind Apintus Labs, for FY 2023. Net loss was -₹59,025 (0% margin). EBITDA was -₹44,025 (0% margin). Revenue has grown at a compounded annual rate of -100% over three years and -100% over five years.
- -₹59,025Net loss · 0% margin
- -₹44,025EBITDA · 0% margin
- ₹1 LakhPaid-up capital
- 7Employees (provident fund records)
- -100%Revenue CAGR, 3 years
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Apintus Labs Private Limited are on its company page.
Detailed financial statements for Apintus Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Apintus Labs
Apintus Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Apintus Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Apintus Labs
10 companies that operate in the same segment as Apintus Labs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apintus Labs
Apintus Labs is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
Apintus Labs has 7 employees.
Apintus Labs, based in Thane, focuses on producing manufactured goods, chemicals, producing pharmaceutical products, and api production. Produces high-quality APIs and chemical intermediates for industrial applications. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Apintus Labs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Apintus Labs operates through Apintus Labs Private Limited.
The legal entities of Apintus Labs currently have 3 directors, including Manohar Vishwanatham Bommanpad, Shailaja Bommanpad Manohar, Satish Ramshankar Varma.